
Popular, Inc. (BPOP) reported strong second-quarter 2025 adjusted earnings per share of $3.09, significantly surpassing the Zacks Consensus Estimate of $2.60, driven by a 9% year-over-year increase in total revenues to $800 million. This revenue growth was primarily fueled by an 11.1% rise in net interest income and a 1.3% increase in non-interest income, alongside sequential growth in loans and deposits. While credit quality improved with a 13.1% decline in non-performing assets, the positive results were partially offset by a 4.9% increase in operating expenses and higher provisions for credit losses, with capital ratios also seeing a modest year-over-year decline.
Popular, Inc. (BPOP) delivered a robust second-quarter 2025 performance, highlighted by an adjusted EPS of $3.09 that significantly surpassed the $2.60 consensus estimate and grew from $2.46 in the prior-year quarter. The primary driver of this outperformance was a 9% year-over-year increase in total revenues to $800 million, underpinned by an 11.1% rise in net interest income (NII) to $631.5 million. This NII strength was fueled by a 27 basis point expansion in the net interest margin to 3.49% and sequential growth in the balance sheet, with loans increasing 2.5% to $37.4 billion and deposits rising 2.1% to $67.2 billion. While credit quality showed improvement, evidenced by a 13.1% year-over-year decline in non-performing assets, this positive was tempered by a 4.6% increase in the provision for credit losses to $48.9 million. Key headwinds include a 4.9% rise in operating expenses, driven by personnel and business promotion costs, and a modest decline in capital ratios, with the Common Equity Tier 1 ratio falling to 15.91% from 16.48% a year ago. The company's execution of a $112 million share repurchase program during the quarter signals management's confidence despite these pressures.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Overall Sentiment
strongly positive
Sentiment Score
0.70
Ticker Sentiment